Related Experiment Video
Updated: Apr 30, 2026

09:04
A Burrowing/Tunneling Assay for Detection of Hypoxia in Drosophila melanogaster Larvae
Published on: March 27, 2018
8.1K
Low-dose radiation suppresses Pokemon expression under hypoxic conditions
Zeitschrift Fur Naturforschung. C, Journal of Biosciences
|April 30, 2014
Summary
This study investigates the role of the Pokemon transcription factor in the unfolded protein response (UPR) under hypoxic conditions. Low-dose radiation (LDR) represses Pokemon, impacting ER stress and UPR, offering insights into cancer development and therapy.
Area of Science:
- Cellular Biology
- Molecular Oncology
- Radiation Biology
Background:
- Cobalt chloride (CoCl2)-induced hypoxia influences endoplasmic reticulum (ER) stress and intracellular factors.
- The transcription factor Pokemon is differentially regulated by low-dose radiation (LDR) under hypoxic conditions.
- Limited data exist on Pokemon's involvement in the unfolded protein response (UPR) during hypoxia.
Purpose of the Study:
- To elucidate the role of the Pokemon transcription factor in the UPR under hypoxic conditions.
- To investigate how LDR affects Pokemon expression and its subsequent impact on UPR.
Main Methods:
- Pokemon was identified as a differentially expressed gene under hypoxia.
- The effect of LDR on Pokemon regulation was examined.
- Cellular responses, including ER chaperones and stress sensors, were analyzed in cells with altered Pokemon expression.
Main Results:
- Pokemon expression was repressed by LDR under hypoxic conditions.
- Both ER chaperones and ER stress sensors were affected by hypoxia.
- Altering Pokemon expression (up- or down-regulation) mimicked the effects of hypoxic conditions on ER stress markers.
Conclusions:
- Pokemon plays a significant role in modulating the UPR under hypoxic conditions.
- The Pokemon pathway, influenced by LDR, is crucial for understanding oncogenesis, senescence, and cellular differentiation.
- This research provides a foundation for developing novel therapeutic radiopharmaceuticals targeting the UPR and Pokemon pathway.

